BIO on the Bayou: An Academic Research Expo

Hosted by LSU Health, Tulane University & the New Orleans BioInnovation Center

---

Platinum Sponsor: NOLABA

Gold Sponsor: Baker Donelson

---

2019 Focus Areas: Neuroscience & Cardiovascular + Related Chronic Diseases

Tuesday December 10th, 2019 @ The New Orleans Bioinnovation Center

---

LSU Health, Tulane University and the New Orleans BioInnovation Center have banded together as one to lower the activation energy required for industry, investors, foundations and other collaborators to partner with us. Because we know our collaborators time is valuable, we are presenting our expertise in the areas of Neuroscience and Cardiovascular + Related Chronic Diseases in New Orleans together for our Annual Academic Research Expo.

Join us for this second annual version of our signature event!

---

BotB 2019 AGENDA

MORNING THEME: CARDIOVASCULAR / METABOLIC DISEASE

9:45 - 10:00 WELCOME & OPENING COMMENTS

10:00 - 10:10 David Lefer, PhD, Director Cardiovascular Center of Excellence (LSU Health), Renal Denervation as Novel Therapeutic for Heart Failure

10:10 - 10:20 Stryder Meadows, PhD Assistant Professor, Cell & Molecular Biology (TU), Therapeutic discovery for vascular anomalies: arteriovenous malformations

10:20 - 10:30 Traci Goodchild, PhD, Director, Cardiovascular Center Translational Core Laboratory (LSU Health), Translational Research in Reverse and Preclinical Testing

10:30 - 10:40 Minolfa Prieto, MD, PhD, Associate Professor, Physiology (TU), Role of the prorenin receptor in the collecting duct in controlling blood pressure

10:40 - 10:50 Daniel R. Kapusta, PhD, PI and Director, COBRE Cardiovascular Research Program (LSU Health), Development of Orally Active Non-Peptide Ligands for Treatment of Hypertension and Management of Hyponatremia in Water Retaining States

---

10:50 - 11:10 COFFEE BREAK & NETWORKING

---

11:10 - 11:20 Patrick Delafontaine, MD, Executive Dean, School of Medicine (TU), IGF-1, Cardiovascular Disease and Skeletal Muscle Wasting

11:20 - 11:30 Eric Lazartigues, PhD, Professor of Pharmacology & Experimental Therapeutics (LSU Health), ADAM17 and ACE2 as New Targets for the Regulation of Sympathoexcitation

11:30 - 11:40 Cooper Woods, PhD, Associate Professor, Physiology and Medicine (TU), Identifying pre-stroke biomarkers using fresh post-stroke vascular samples

11:40 - 11:50 Frank Smart, MD, Chief, Section of Cardiology (LSU Health), A Novel Method of Heart Failure Detection and Characterization Using Machine Learning

11:50 - 12:00 Nassir Marrouche, MD, Professor of Medicine, Head of Center for Arryhthmia (TU), Personalized path to managing arrhythmias

12:00 - 12:10. Sarah Lindsey, PhD, Associate Professor, Pharmacology (TU), Eliciting Estrogen’s Protective Vascular Effects

---

LUNCH & KEYNOTE PANEL: 12:10 - 1:30pm

OPENING REMARKS by Ellen Lee, Director of Community and Economic Development, City of New Orleans (On behalf of Mayor LaToya Cantrell)

Moderator: Jeanette Weiland, NOLABA

Lili M. Portilla, National Center for Advancing Translational Discoveries (NCATS)

Christie Canaria, NCI SBIR Development Center

Sunyoung Kim, Chosen Diagnostics

Sharon Semones, Eli Lilly & Co.

---

AFTERNOON THEME: NEUROSCIENCE

1:30 - 1:40 Axosim (Lowry Curley, PhD, CEO) (TU), Nerve-on-a-chip and brain organoid testing for drug CNS toxicity

1:40 - 1:50 Nicolas G. Bazan, MD, PhD, Director, Neuroscience Center of Excellence (LSU Health), Therapeutic Targeting of Senescence Programming by Elovanoids for Age-Related Macular Degeneration, Alzheimer's, Stroke, and other Neurodegenerative Diseases

1:50 – 2:00 Jill Daniel, PhD, Director, Tulane Brain Institute (TU), Strategic areas and focuses for the Tulane Brain Institute

2:00 - 2:10 Haydee E. P. Bazan, PhD, Professor of Neuroscience, Ophthalmology, Biochemistry, & Molecular Biology (LSU Health), New Therapeutic Avenue for Dry Eye and Other Cornea Pathologies

2:10 - 2:20 Gregory Bix, MD, PhD, Professor, Neurosurgery (TU), The role of the Extracellular matrix and derived molecules in improving post-stroke neurological outcomes

---

2:20 - 2:40 COFFEE BREAK & NETWORKING

---

2:40 - 2:50 Jeffrey D. Erickson, PhD, Associate Professor, Neuroscience. Pharmacology & Experimental Therapeutics (LSU Health), Novel Presynaptic Agents to Prevent Glutamate-Induced Neural Injury

2:50 – 3:00 Stacy Drury, MD, Director, Behavioral and Neurodevelopmental Genetics Laboratory, Associate Professor, Psychiatry (TU), Interventions in infants going through opioid withdrawal

3:00 - 3:10 South Rampart Pharma (Hernan Bazan, MD FACS, CEO & Co-Founder) (LSU Health), Novel Non-narcotic Analgesics Fulfill large Unmet Needs in Acute and Chronic Pain

3:10 - 3:20 Ricardo Mostany, PhD, Associate Professor, Pharmacology (TU), Synaptic plasticity in aging and neurodegenerative diseases

3:20 - 3:30 Jennifer J. Lentz, PhD, Associate Professor of Otorhinolaryngology & Biocommunications and Neuroscience (LSU Health), Precision Medicine for Deafness and Blindness in Usher Syndrome

3:30 - 3:40 Patricia Molina, MD, PhD, Director, Alcohol and Drug Abuse Center of Excellence (LSU Health), Alcohol and Drug Abuse Center of Excellence: Discovering Neuropathological Mechanisms of Comorbid Conditions

---

3:40 - 4:00 CLOSING REMARKS

4:00 - 7:00 CLOSING RECEPTION & NETWORKING

---

Platinum Sponsor: NOLABA

Gold Sponsor: Baker Donelson